info787351Jan 23, 20122 min readBioRelix Inc. Secures $500,000 Investment from Connecticut InnovationsAntibiotics developer utilizes novel riboswitch-based drug discovery platform Connecticut Innovations (CI), the state’s quasi-public...
info787351Oct 13, 20113 min readAxerion Therapeutics Inc. Receives $400,000 Follow-on Investment from Connecticut InnovationsNew Haven-based biotech company advances innovative treatments for neurological injuries and diseases Connecticut Innovations (CI), the...
